How did AMED's revenue and expenses trend in Q4 2024 compared to previous quarters?

**Amedisys, Inc. (AMED) experienced a general upward trend in revenue and a fluctuating expense pattern over the fourth quarter (Q4) 2024, compared to previous quarters**: 1. **Revenue Trend**: - Q4 2024: The total revenue for Amedisys was $598.05 million. - Q3 2024: Revenue was $587.67 million. - Q2 2024: Revenue peaked at $591.19 million. - Q1 2024: Revenue was $571.41 million. - The highest revenue was recorded in Q2 2024, followed by a slight decrease in Q3 and a significant increase in Q4, indicating a seasonal or strategic adjustment in revenue generation. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |AMED|AMED.O|Amedisys|2023 Q4|1.5521364115118563|5.70788E8|185| |AMED|AMED.O|Amedisys|2024 Q1|2.7004487867301474|5.71414E8|185| |AMED|AMED.O|Amedisys|2024 Q2|6.911611521824048|5.91187E8|185| |AMED|AMED.O|Amedisys|2024 Q3|5.651188252489496|5.87671E8|185| 2. **Expense Trend**: - No specific data on expenses for Q4 2024 is available. - However, from Q3 2024 to Q2 2024, operating income decreased from $30.3 million to $54.5 million, and then increased to $77.3 million in Q2 2024. - The cost of services, including depreciation, increased by 8.3% in Q2 2024, leading to a fall in gross margin from 44.7% to 42.6%. - SG&A expenses on salaries and benefits rose by 3% and 4.4% in Q2 and Q3 2024, respectively. - The adjusted operating profit increased from $58.1 million in Q3 2024 to $77.3 million in Q2 2024. 3. **Net Income and Diluted Earnings Per Share (EPS)**: - Net income attributable to Amedisys, Inc. was $16.9 million in Q4 2024. - This is an increase from the $16.5 million reported in Q3 2024. - The diluted EPS was $0.51 in Q4 2024, compared to $0.79 in Q3 2024. - The improved net income and EPS in Q4 2024 suggest that despite increased expenses, the company managed to maintain profitability and distribute more earnings per share to investors. 4. **Segmental Performance**: - The Home Health segment generated $372.1 million in net service revenue in Q3 2024, with operating income of $54.5 million. - The Hospice segment reported $207.9 million in net service revenue, including $193.7 million in Medicare revenues. - The High Acuity Care segment had net service revenues of $7.7 million. - These segments' performance indicates a strong base of operations, which contributed to the overall revenue and income figures. In summary, Amedisys, Inc. showed a positive revenue trend with a peak in Q2 2024, a slight dip in Q3, and a strong recovery in Q4 2024. Expenses fluctuated, with an increase in cost of services and SG&A expenses, but the company's net income and EPS improved in Q4 2024, suggesting effective cost management and strategic financial planning.